Jan 8 (Reuters) - SalvaRx Group Plc SALVS.L :
* DENHAM EKE HAS BEEN APPOINTED AS CHIEF FINANCIAL OFFICER AND AS A DIRECTOR OF COMPANY
* SHAREHOLDERS APPROVED SALE OF CO'S 94.2 PERCENT INTEREST IN SALVARX LTD TO PORTAGE BIOTECH INC FOR A CONSIDERATION OF $67.5 MILLION
* SHAREHOLDERS ALSO APPROVED TRANSFER OF 660.6 MILLION CONSIDERATION SHARES ON A PRO-RATA BASIS TO SHAREHOLDERS